Iridian Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $103M | Sell |
|
|||||
|
2020
Q3 | $164M | Sell |
|
|||||
|
2020
Q2 | $170M | Sell |
|
|||||
|
2020
Q1 | $177M | Buy |
|
|||||
|
2019
Q4 | $186M | Sell |
|
|||||
|
2019
Q3 | $174M | Sell |
|
|||||
|
2019
Q2 | $234M | Sell |
|
|||||
|
2019
Q1 | $296M | Sell |
|
|||||
|
2018
Q4 | $243M | Buy |
|
|||||
|
2018
Q3 | $329M | Buy |
|
|||||
|
2018
Q2 | $186M | Buy |
|
|||||
|
2018
Q1 | $1.11M | Buy |
|